2015
DOI: 10.1016/j.ejso.2015.07.021
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ

Abstract: Background. A role for radiotherapy after mastectomy for ductal carcinoma in situ (DCIS) is unclear. Using a prospective audit of DCIS detected through the NHS Breast Screening Programme we sought to determine a rationale for the use of postmastectomy radiotherapy for DCIS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
23
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 14 publications
0
23
0
Order By: Relevance
“…In addition, available data include the use of endocrine therapy with linkage to outcomes. [2,3] Conversely, one limitation of the present study, in keeping with the recently published retrospective series [2][3][4]12] is its observational nature with the consequent difficulty in accounting for all possible confounders. Follow up is also relatively short in the context of the long natural history of DCIS.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…In addition, available data include the use of endocrine therapy with linkage to outcomes. [2,3] Conversely, one limitation of the present study, in keeping with the recently published retrospective series [2][3][4]12] is its observational nature with the consequent difficulty in accounting for all possible confounders. Follow up is also relatively short in the context of the long natural history of DCIS.…”
Section: Discussionmentioning
confidence: 91%
“…The present prospective cohort study contrasts with recent but retrospective studies of US [2,3] and European data. [12] Unlike those series, we report prospectively collected data from the setting of an established national breast screening programme, with built in quality assurance of imaging, surgery, pathology and RT. [10,13] An additional major strength, in contrast to other studies including the randomised clinical trials, is the prospective collection of margin status, an area of significant international controversy.…”
Section: Discussionmentioning
confidence: 99%
“…More recent results suggest that factors such as close margins, large lesion size and microinvasion may be sufficient to consider RT following mastectomy for DCIS to reduce the risk of ipsilateral recurrence [135]. However, the risk of recurrence is small even in patients who did not receive RT, so the benefit of radiation may be limited.…”
Section: A Uk-wide Prospective Audit Of Dcis: the Sloane Projectmentioning
confidence: 99%
“…LRR after mastectomy for DCIS has historically been demonstrated as low, with the UK SLOANE audit reporting a 1% LRR,13 and a meta-analysis incorporating 1574 patients demonstrating an LRR of 1.4% 14. DCIS is associated with less clinically apparent disease, making identification of lesions intraoperatively more difficult 1.…”
mentioning
confidence: 99%
“…In 2007, 27% of patients undergoing a mastectomy for DCIS had an SSM with immediate breast reconstruction compared with 10% in invasive disease 3. The higher rates of SSM use in DCIS are to be expected as these patients are unlikely to require adjuvant radiotherapy 13. Despite SSMs increasing use in DCIS, there are little data on oncological outcomes in simple mastectomy compared with SSM.…”
mentioning
confidence: 99%